CATALYST FINANCIAL PARTNERS LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1927537 BOSTON, MA

Position in VRTX

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$655,683

-$82,894 QoQ

Shares Held

1,320

-20.2% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.13%

of 13F equity value

Holder Rank

#984

of 1,735 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

CATALYST FINANCIAL PARTNERS LLC holds $1,897,610 across 5 Biotechnology names. VRTX ranks #1 (34.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	1,320	$655,683
2	RVMD	Revolution Medicines, Inc.	2,725	$510,338
3	DMAC	DiaMedica Therapeutics Inc.	38,457	$270,737
4	ABOS	Acumen Pharmaceuticals, Inc.	89,699	$239,496
5	REGN	Regeneron Pharmaceuticals, Inc.	355	$221,356

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$655,683	1,320	-20.2%	Shares	Sole	2026-07-30
2026-03-31	$738,577	1,654	+24.2%	Shares	Sole	2026-05-12
2025-12-31	$603,875	1,332	+19.6%	Shares	Sole	2026-02-04
2025-09-30	$436,286	1,114	-4.8%	Shares	Sole	2025-11-12
2025-06-30	$520,884	1,170	-14.0%	Shares	Sole	2025-08-14
2025-03-31	$659,840	1,361	+21.0%	Shares	Sole	2025-05-02
2024-12-31	$453,037	1,125	+3.6%	Shares	Sole	2025-01-30
2024-09-30	$505,076	1,086	+0.1%	Shares	Sole	2024-10-28
2024-06-30	$508,561	1,085	+6.6%	Shares	Sole	2024-07-25
2024-03-31	$425,534	1,018	+4.2%	Shares	Sole	2024-04-23
2023-12-31	$397,531	977	+3.8%	Shares	Sole	2024-02-07
2023-09-30	$327,223	941	+8.2%	Shares	Sole	2023-10-26
2023-06-30	$306,161	870	+16.2%	Shares	Sole	2023-08-02
2023-03-31	$235,987	749	—	Shares	Sole	2023-04-11
No filing history on record for this holder in this stock.